Le Lézard
Classified in: Covid-19 virus

Global Hemoglobin A1C (HbA1C) Testing Strategic Research Report 2023: Market to Reach $2.3 Billion by 2030 from $1.4 Billion in 2022 - Benefits of POC HbA1c Tests Over Lab Tests Drives Adoption - ResearchAndMarkets.com


The "Hemoglobin A1C (HbA1C) Testing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Global Hemoglobin A1C (HbA1C) Testing Market to Reach $2.3 Billion by 2030

The global market for Hemoglobin A1C (HbA1C) Testing estimated at US$1.4 Billion in the year 2022, is projected to reach a revised size of US$2.3 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2022-2030. Ion-Exchange High Performance Liquid Chromatography (HPLC), one of the segments analyzed in the report, is projected to record 7.6% CAGR and reach US$915.7 Million by the end of the analysis period. Growth in the Immunoassays segment is estimated at 8.4% CAGR for the next 8-year period.

The report discusses the impact of the COVID-19 pandemic on the utilization of Hemoglobin A1C (HbA1C) laboratory tests, highlighting a new challenge of underutilization. It also provides insights into the competition within the HbA1C testing market, including the global key competitors' percentage market share in 2022.

The importance of HbA1C testing in the monitoring and management of diabetes is emphasized, along with its role in diabetes diagnosis and management. The report includes information on the interpretation of HbA1C levels in NGSP (National Glycohemoglobin Standardization Program) and IFCC (International Federation of Clinical Chemistry and Laboratory Medicine) units as per the American Diabetes Association.

The global market analysis and prospects for HbA1C testing are presented, with a focus on rapid growth in the world HbA1C testing market. While developed regions lead the market, Asia-Pacific is expected to spearhead long-term growth. Chromatography-based Hb testing devices are highlighted as critical tools in the market, with ion-exchange HPLC (High-Performance Liquid Chromatography) tests gaining prominence as reliable diabetes screening tools.

The report also discusses the use of HbA1C testing in point-of-care (POC) settings for diabetes screening and management. It mentions the increasing interest in rapid POC HbA1C testing, which is expected to receive special attention in diabetes screening efforts. Additionally, recent market activity and world brands in the HbA1C testing market are highlighted. The competitive market presence of players worldwide in 2022 is categorized as strong, active, niche, or trivial.

The U.S. Market is Estimated at $397.5 Million, While China is Forecast to Grow at 9.5% CAGR

The Hemoglobin A1C (HbA1C) Testing market in the U.S. is estimated at US$397.5 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$274.2 Million by the year 2030 trailing a CAGR of 9.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.3% and 6.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

What`s New?

Key Attributes:

Report Attribute Details
No. of Pages 511
Forecast Period 2022 - 2030
Estimated Market Value (USD) in 2022 $1.4 Billion
Forecasted Market Value (USD) by 2030 $2.3 Billion
Compound Annual Growth Rate 6.4%
Regions Covered Global

MARKET TRENDS & DRIVERS

FOCUS ON SELECT PLAYERS (Total 110 Featured)

For more information about this report visit https://www.researchandmarkets.com/r/etlpo2

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


These press releases may also interest you

at 05:15
The "Global Continuing Medical Education Market - Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering. The global continuing medical education market is expected to reach a value of $13.52 billion by 2028 from...

at 05:00
The "Wilms Tumor Protein Global Market Report 2024" has been added to ResearchAndMarkets.com's offering. The Wilms Tumor Protein market size is expected to see strong growth in the next few years. It will grow to $4.06 billion in 2028 at a compound...

at 05:00
Freegold Ventures Limited is pleased to report drill results from the Saddle Zone drilling as part of the 2023 exploration program at Golden Summit. The 2023 program has been very successful in demonstrating significant expansion potential with...

at 03:45
PCs will be the main driver of growth in the AI edge processor market over the next four years, according to new research from Omdia. This was among the results announced by Omdia in the 2023 edition of its AI Processors for the Edge Forecast, which...

at 03:01
SolarBank Corporation (Cboe CA: SUNN) ("SolarBank" or the "Company") reports second quarter 2024 interim financial results. All financial figures are in Canadian dollars and in accordance with International...

at 02:00
Centamin will announce its audited financial results for the twelve months ended 31 December 2023 on Thursday, 21 March 2024.The Company will host a webcast presentation on the same day, at 08.30 GMT, to discuss the results with investors and...



News published on and distributed by: